Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"

NCT00155844 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00155844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00155844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2003
Completion date
July 31, 2004
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelocytic leukemia